Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-08

FDA Approved: IRON SUCROSE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved the original application for Iron Sucrose, a generic injectable iron product, indicating approval for use in treating iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron sucrose (iron sucrose)

Snippet

ORIG AP for IRON SUCROSE (IRON SUCROSE)